Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

2,042.95
+13.020.64%
Number of Gainers:691
Number of Losers:313
Number of Flat:15
PE:- -
High:2,044.72
Open:2,030.21
Low:2,030.21
Close:2,029.94
Volume:4.94B
Turnover:581.81B
Market Cap:97.58T
Float Cap:91.33T

Loading ...

Coinbase price target lowered to $280 from $325 at Citizens

TIPRANKS
·
Oct 09

Gold Price Analysis: Wave B Retracement Nears Completion, Two Scenarios Ahead

Deep News
·
Oct 09

Gold Recovers After Dip, Buy-the-Dip Strategy Remains Valid as Retreat Continues

Deep News
·
Oct 09

World Gold Council: Global Central Banks Extend Summer Buying Spree with 39 Tonnes of Net Gold Purchases in August

Stock News
·
Oct 09

China's Central Bank Governor Met with Goldman Sachs President - Central Bank Statement

THOMSON REUTERS
·
Oct 09

Northland Securities Downgrades Semtech to Market Perform From Outperform

MT Newswires Live
·
Oct 09

Synchrony Financial : Bmo Initiates Coverage with Market Perform Rating; Target Price $81

THOMSON REUTERS
·
Oct 09

BlackRock Smaller Companies Trust Wins Shareholder Approval for Renewed Buyback Authority

TIPRANKS
·
Oct 09

Nvidia Changed How it Talks About Cash Flow. What That Means for Buybacks

Dow Jones
·
Oct 09

BioNTech price target lowered to $114 from $122 at BofA

TIPRANKS
·
Oct 09

National Healthcare Properties (NHP) Reaffirms Dividend, Is The Stock Still A Bargain?

Simply Wall St.
·
Oct 09

Lilly Says Phase 3b Together-PsO Data Show Broader Biomarker Shifts with Taltz Plus Zepbound vs Taltz Alone

Reuters
·
Oct 09

Is iPhone 18 Demand Cooling Off? Here's How Deep Apple Reportedly is Cutting Component Orders

Dow Jones
·
Oct 09

Learn Why The Bull Case For GlobalFoundries Stock Could Change Following U.S. AI Chip Packaging Deal

Simply Wall St.
·
Oct 09

Eli Lilly price target lowered to $1,341 from $1,344 at BofA

TIPRANKS
·
Oct 09

How Oster Blender Launches Will Impact Newell Brands Stock

Simply Wall St.
·
Oct 09

Eli Lilly - Taltz and Zepbound Together Show Greater Reductions in Inflammatory Immune Activity

THOMSON REUTERS
·
Oct 09

Eli Lilly: Improvements were Maintained or Further Improved Through Week 52, with Safety Consistent with Known Profile of Each Respective Medicine

THOMSON REUTERS
·
Oct 09

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Advance Understanding of the Interconnected Immune and Metabolic Biology in Adults with Psoriasis and Obesity

THOMSON REUTERS
·
Oct 09

Nikkei 225 Index Rises 1.06% This Week to 69030.92

Dow Jones
·
Oct 09